144 results on '"O'Connor, Christopher"'
Search Results
2. Relationship of Race With Functional and Clinical Outcomes With the REHAB‐HF Multidomain Physical Rehabilitation Intervention for Older Patients With Acute Heart Failure
3. Spatial Heterogeneity of Glomerular Phenotypes Impacts Kidney Biopsy Findings
4. A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study
5. Clinical Predictors of Adherence to Exercise Training Among Individuals With Heart Failure
6. Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial
7. Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year Outcomes
8. Abstract 12124: A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study
9. Abstract 13324: One-Year Outcomes in Patients With Cardiogenic Shock: Insights From the Inova-Shock Registry
10. Participation in a Heart Failure Clinical Trial
11. Myocarditis Temporally Associated With COVID-19 Vaccination
12. Differences in NT‐proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction
13. Prognostic Role of Prior Heart Failure Hospitalization Among Patients Hospitalized for Worsening Chronic Heart Failure
14. Polygenic Score for β-Blocker Survival Benefit in European Ancestry Patients With Reduced Ejection Fraction Heart Failure
15. Abstract 13829: Index Event, Clinical Outcomes and Response to Vericiguat in the Victoria Trial
16. Abstract 16433: Quality Initiative Tied to Physician Reimbursement Significantly Improves Sacubitril/valsartan and Spironolactone Use Among Patients With Heart Failure With Reduced Ejection Fraction
17. Challenges and Potential Improvements to Patient Access to Pharmaceuticals
18. Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical Trials
19. Transcatheter Aortic Valve Replacement in Low-Population Density Areas
20. Sex Differences in Quality of Life and Clinical Outcomes in Patients With Advanced Heart Failure
21. Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus
22. Clinical Implications of the New York Heart Association Classification
23. Rationale and Design of the VITALITY-HFpEF Trial
24. Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points
25. Renal Function Trajectories and Clinical Outcomes in Acute Heart Failure
26. Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure
27. In patients with uncontrolled type 2 diabetes, are GLP-1 agonists more effective than SGLT-2 inhibitors in lowering HbA1c?
28. Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes
29. Differences Between Patients Enrolled Early and Late During Clinical Trial Recruitment
30. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury
31. Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion
32. Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients
33. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
34. Interaction of Body Mass Index on the Association Between N‐Terminal‐Pro‐b‐Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND‐HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)
35. Novel Mitochondria-Targeting Peptide in Heart Failure Treatment
36. Reassessing Phase II Heart Failure Clinical Trials
37. Associations of Body Mass Index With Laboratory and Biomarkers in Patients With Acute Heart Failure
38. Effects of Coping Skills Training on Quality of Life, Disease Biomarkers, and Clinical Outcomes in Patients With Heart Failure
39. Abstract 13158: Hospitalization for De Novo versus Worsening Chronic Heart Failure: Insights From the ASCEND-HF Trial
40. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points
41. Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure
42. Implications of Using Different Definitions on Outcomes in Worsening Heart Failure
43. Baseline Hemodynamics and Response to Contrast Media During Diagnostic Cardiac Catheterization Predict Adverse Events in Heart Failure Patients
44. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure
45. Glomerular Aging and Focal Global Glomerulosclerosis
46. Abstract 10990: Regulatory Implications of Different Definitions and Outcomes in Worsening Heart Failure
47. Abstract 18407: Identifying Patients With Acute Heart Failure who Require a Critical Care Admission: ASCEND-HF Insights
48. Abstract 17580: Angina Pectoris in Diabetic Patients: Insights From the Duke Databank for Cardiovascular Disease
49. Abstract 17587: Implications of Angina Pectoris on Quality of Life, Functional Capacity and Clinical Outcomes in Chronic Heart Failure Patients: Insights From HF-ACTION
50. Abstract 17304: Sudden Cardiac Death After Acute Heart Failure Hospitalization: Insights From ASCEND-HF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.